The embryonic-fetal failure of the lymphatic structures to develop entirely is a condition that is practically incompatible with extrauterine life and is called Lymphatic Agenesis. LYMPHATIC AGENESIS: Most congenital clinical manifestations due to a deficit in the development of lymphatic structures are more frequently associated with anatomopathological pictures of hypoplasia of the lymphatic-lymph node structures or, in much rarer cases, partial aplasia of major lymphatic structures, such as, for example, the thoracic duct.  We invite you to visit other articles

Please see “Lymphatic Microsurgery.”  We invite you to visit other articles Lymphaticsurgery

It is defined as the loss of the histo- and cyto-architecture of vascular tissue structures and is at the basis of most congenital malformative pathologies that affect vascular structures, whether arterial, venous, or lymphatic.  ANGIODYSPLASIA: Definition of Angiodysplasia Angiodysplasia is a disease of the blood vessels in which structural abnormalities occur. These abnormalities can affect arteries, veins, or capillaries. In the gastrointestinal context, angiodysplasia is often located in the colon, small intestine, or stomach. Vascular malformations can vary in size

The SUCCULAVIO-JUGULAR ANGLE is formed by the confluence of the left internal jugular vein and the left subclavian vein. At this level, the thoracic duct terminates, emptying the lymph it contains into the venous system.  SUCCULAVIO-JUGULAR ANGLE: Anatomy of the Succulavio-Jugular Angle The succulavio-jugular angle is formed by the junction of the subclavian vein and the internal jugular vein. The subclavian vein is one of the major veins of the arm, carrying deoxygenated blood back to the heart. The internal

Antiplatelet agents are a group of drugs that act by inhibiting platelet aggregation, effectively blocking the formation of thrombi. Prototypes of this category of drugs include aspirin and ticlopidine, which achieve this goal through different mechanisms, respectively influencing prostaglandin metabolism and preventing the action of ADP (a receptor on the platelet membrane).  ANTIPLATELET AGENTS: They are generally used for antithrombotic prophylaxis in patients with coagulation disorders or at risk of thromboembolic events. In lymphology, they are used in the post-operative

Anticoagulants are an extremely heterogeneous category of drugs (heparin, antiplatelet agents, coumarins, etc.), but they all share a common goal, which is to slow down and regulate the normal coagulation processes in patients with altered hemostatic mechanisms, who, for various reasons, exhibit a pronounced thrombophilia and therefore an increased risk of thromboembolism.  ANTICOAGULANTS : Types of Anticoagulants Heparin: Heparin is a rapidly acting anticoagulant mainly used to prevent and treat blood clots in the hospital setting. It is administered intravenously or